Perceptions and Barriers on the Use of Proprotein Subtilisin/Kexin Type 9 Inhibitors in Heterozygous Familial Hypercholesterolemia (From a Survey of Primary Care Physicians and Cardiologists)
- Resource Type
- Article
- Source
- In
The American Journal of Cardiology 1 August 2021 152:57-62 - Subject
- Language
- ISSN
- 0002-9149